A detailed history of Charles Schwab Investment Management Inc transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 602,227 shares of SWTX stock, worth $22.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
602,227
Previous 528,614 13.93%
Holding current value
$22.5 Million
Previous $19.9 Million 3.1%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$32.04 - $42.76 $2.36 Million - $3.15 Million
73,613 Added 13.93%
602,227 $19.3 Million
Q2 2024

Aug 12, 2024

BUY
$36.06 - $47.62 $383,714 - $506,724
10,641 Added 2.05%
528,614 $19.9 Million
Q1 2024

May 08, 2024

BUY
$36.5 - $52.5 $617,069 - $887,565
16,906 Added 3.37%
517,973 $25.5 Million
Q4 2023

Feb 06, 2024

BUY
$18.94 - $37.24 $1.46 Million - $2.88 Million
77,303 Added 18.24%
501,067 $18.3 Million
Q3 2023

Nov 08, 2023

BUY
$23.12 - $31.38 $1.37 Million - $1.86 Million
59,138 Added 16.22%
423,764 $9.8 Million
Q2 2023

Aug 09, 2023

BUY
$23.15 - $32.71 $1.23 Million - $1.74 Million
53,247 Added 17.1%
364,626 $9.56 Million
Q1 2023

May 11, 2023

BUY
$24.97 - $34.05 $10,087 - $13,756
404 Added 0.13%
311,379 $8.01 Million
Q4 2022

Feb 13, 2023

BUY
$21.73 - $28.72 $1.6 Million - $2.11 Million
73,432 Added 30.91%
310,975 $8.09 Million
Q3 2022

Nov 14, 2022

BUY
$24.1 - $39.66 $760,596 - $1.25 Million
31,560 Added 15.32%
237,543 $6.78 Million
Q2 2022

Aug 15, 2022

BUY
$18.36 - $60.07 $153,471 - $502,125
8,359 Added 4.23%
205,983 $5.07 Million
Q1 2022

May 13, 2022

BUY
$48.97 - $65.46 $311,694 - $416,652
6,365 Added 3.33%
197,624 $11.2 Million
Q4 2021

Feb 11, 2022

BUY
$53.3 - $75.84 $161,445 - $229,719
3,029 Added 1.61%
191,259 $11.9 Million
Q3 2021

Nov 16, 2021

SELL
$62.66 - $88.26 $307,911 - $433,709
-4,914 Reduced 2.54%
188,230 $11.9 Million
Q2 2021

Aug 16, 2021

BUY
$67.45 - $85.63 $900,997 - $1.14 Million
13,358 Added 7.43%
193,144 $15.9 Million
Q1 2021

May 17, 2021

BUY
$65.1 - $93.59 $385,391 - $554,052
5,920 Added 3.4%
179,786 $13.2 Million
Q4 2020

Feb 16, 2021

BUY
$48.36 - $77.92 $1.56 Million - $2.52 Million
32,358 Added 22.87%
173,866 $12.6 Million
Q3 2020

Nov 13, 2020

BUY
$36.14 - $51.99 $1.96 Million - $2.82 Million
54,187 Added 62.05%
141,508 $6.75 Million
Q2 2020

Aug 14, 2020

BUY
$22.98 - $48.57 $622,229 - $1.32 Million
27,077 Added 44.95%
87,321 $3.67 Million
Q1 2020

May 15, 2020

BUY
$20.44 - $41.21 $26,837 - $54,108
1,313 Added 2.23%
60,244 $1.63 Million
Q4 2019

Feb 07, 2020

BUY
$17.74 - $39.52 $1.05 Million - $2.33 Million
58,931 New
58,931 $2.27 Million

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.34B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.